Delighted to welcome Manchester Royal Infirmary onto the #MAST trial as our seventh site! Pleased to be able to expand our coverage for this important trial of #GutMicrobiome manipulation with #IMT #FMT before #HCT; find out more here: www.imperial.ac.uk/metabolism-d... @imperialmdr.bsky.social

Want to know more about why we are looking at the #GutMicrobiome #IMT #HCT as therapy? Find out even more here: youtu.be/zDd1qdVCa6A?...

The #MAST trial is pushing forward, investigating the impact of #IMT #FMT prior to #HCT in seven UK centres #HaemSky #MicrobiomeSky #GastroSky @imperialmdr.bsky.social @bloodcanceruk.bsky.social ruk.bsky.social @anthonynolan.bsky.social. Find out more from our poster or our website: rb.gy/myizsb

MAST is moving onwards and upwards and now up to 18 recruited patients. We push on, hoping to see how gut #microbiome manipulation with #IMT #FMT can help our patients with #BloodCancer #HCT @bloodcanceruk.bsky.social @anthonynolan.bsky.social

Now out - protocol paper for the #MAST trial, exploring #IMT #FMT to #prehabilitate the #GutMicrobiome in #BloodCancer patients receiving #HCT, now in #BMJOpen: doi.org/10.1136/bmjo... . Grateful to #MRC #DPFS for funding and #EnteroBiotix as project partners #HaemSky #MicrobiomeSky #GastroSky

We are looking forward to #ASH2024, and pleased that our poster on the #MAST trial will be on display: ashpublications.org/blood/articl... . Please come along and discuss #IMT #FMT and the #GutMicrobiome in #BloodCancer #SCT with us!

We are pleased that the #MAST study is live on @bsky.app! Read here 👇 about this trial of modulating the #GutMicrobiome using #IMT #FMT prior to #HCT for #BloodCancer 🩸🦠:
www.imperial.ac.uk/metabolism-d... #MRC #EnteroBiotix @anthonynolan.bsky.social @bloodcanceruk.bsky.social